✦ LIBER ✦
The oral NK1 antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials
✍ Scribed by R. de Wit; J. Herrstedt; B. Rapoport; A.D. Carides; J. Guoguang-Ma; M. Elmer; C. Schmidt; J.K. Evans; K.J. Horgan
- Book ID
- 116427968
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 230 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.